Novartis AG vs J M Smucker Co — how do they compare? Novartis AG trades at $152.38 (market cap $295.37B), while J M Smucker Co trades at $117.5 (market cap $12.54B). The key difference: Novartis AG is far larger — about 23.6× J M Smucker Co's market cap, and J M Smucker Co pays the higher dividend (3.82%). Which is the better fit depends on your goals.
| NVS | SJM | |
|---|---|---|
Market Cap | $295.37B | $12.54B |
Sector | Health | Consumer Staples |
52-Week High | $168.62 | $126.35 |
52-Week Low | $119.31 | $89.53 |
Enterprise Value | $336.69B | $19.57B |
Dividend Yield | 3.07% | 3.82% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →J.M. Smucker is a packaged food company that primarily operates in the U.S. retail channel (87% of fiscal 2022 revenue), but also in U.S. food-service (7%), and international (6%). Its largest segment is pet food and treats (36% of 2022 revenue), with popular brands such as Milk-Bone, Meow Mix, 9Lives, Kibbles 'n Bits, Nature's Recipe, and Rachael Ray Nutrish. Its second-largest category is coffee (35% across channels) with the number-two brand Folgers and number-six Dunkin'. Other large categories are peanut butter (10%), with number-one Jif, fruit spreads (5%) with number-one Smucker's, and frozen hand-held foods (6%) with number-one Uncrustables.
Read more on SJM →